Literature DB >> 25097133

Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer.

Willem Grootjans1, Lioe-Fee de Geus-Oei, Antoi P W Meeuwis, Charlotte S van der Vos, Martin Gotthardt, Wim J G Oyen, Eric P Visser.   

Abstract

OBJECTIVES: Respiratory motion during PET imaging introduces quantitative and diagnostic inaccuracies, which may result in non-optimal patient management. This study investigated the effects of respiratory gating on image quantification using an amplitude-based optimal respiratory gating (ORG) algorithm.
METHODS: Whole body FDG-PET/CT was performed in 66 lung cancer patients. The respiratory signal was obtained using a pressure sensor integrated in an elastic belt placed around the patient's thorax. ORG images were reconstructed with 50%, 35%, and 20% of acquired PET data (duty cycle). Lesions were grouped into anatomical locations. Differences in lesion volume between ORG and non-gated images, and mean FDG-uptake (SUVmean) were calculated.
RESULTS: Lesions in the middle and lower lobes demonstrated a significant SUVmean increase for all duty cycles and volume decrease for duty cycles of 35% and 20%. Significant increase in SUVmean and decrease in volume for lesions in the upper lobes were observed for a 20% duty cycle. The SUVmean increase for central lesions was significant for all duty cycles, whereas a significant volume decrease was observed for a duty cycle of 20%.
CONCLUSIONS: This study implies that ORG could influence clinical PET imaging with respect to response monitoring and radiotherapy planning. KEY POINTS: Quantifying lesion volume and uptake in PET is important for patient management. Respiratory motion artefacts introduce inaccuracies in quantification of PET images. Amplitude-based optimal respiratory gating maintains image quality through selection of duty cycle. The effect of respiratory gating on lesion quantification depends on anatomical location.

Entities:  

Mesh:

Year:  2014        PMID: 25097133     DOI: 10.1007/s00330-014-3362-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  28 in total

1.  Method for transforming CT images for attenuation correction in PET/CT imaging.

Authors:  Jonathan P J Carney; David W Townsend; Vitaliy Rappoport; Bernard Bendriem
Journal:  Med Phys       Date:  2006-04       Impact factor: 4.071

2.  Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.

Authors:  Corneline J Hoekstra; Sigrid G Stroobants; Egbert F Smit; Johan Vansteenkiste; Harm van Tinteren; Pieter E Postmus; Richard P Golding; Bonne Biesma; Frans J H M Schramel; Nico van Zandwijk; Adriaan A Lammertsma; Otto S Hoekstra
Journal:  J Clin Oncol       Date:  2005-11-20       Impact factor: 44.544

Review 3.  Motion in radiotherapy: photon therapy.

Authors:  Stine S Korreman
Journal:  Phys Med Biol       Date:  2012-12-07       Impact factor: 3.609

Review 4.  Motion management in positron emission tomography/computed tomography for radiation treatment planning.

Authors:  Valentino Bettinardi; Maria Picchio; Nadia Di Muzio; Maria Carla Gilardi
Journal:  Semin Nucl Med       Date:  2012-09       Impact factor: 4.446

5.  Four-dimensional (4D) PET/CT imaging of the thorax.

Authors:  S A Nehmeh; Y E Erdi; T Pan; A Pevsner; K E Rosenzweig; E Yorke; G S Mageras; H Schoder; Phil Vernon; O Squire; H Mostafavi; S M Larson; J L Humm
Journal:  Med Phys       Date:  2004-12       Impact factor: 4.071

Review 6.  Use of PET for monitoring cancer therapy and for predicting outcome.

Authors:  Wolfgang A Weber
Journal:  J Nucl Med       Date:  2005-06       Impact factor: 10.057

7.  FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

Authors:  N G Mikhaeel; M Hutchings; P A Fields; M J O'Doherty; A R Timothy
Journal:  Ann Oncol       Date:  2005-06-24       Impact factor: 32.976

8.  Implementation of an automated respiratory amplitude gating technique for PET/CT: clinical evaluation.

Authors:  Guoping Chang; Tingting Chang; Tinsu Pan; John W Clark; Osama R Mawlawi
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

9.  Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.

Authors:  Yoshiaki Zaizen; Koichi Azuma; Seiji Kurata; Eiji Sadashima; Satoshi Hattori; Tetsuro Sasada; Yohei Imamura; Hayato Kaida; Akihiko Kawahara; Takashi Kinoshita; Masatoshi Ishibashi; Tomoaki Hoshino
Journal:  Eur J Radiol       Date:  2012-08-09       Impact factor: 3.528

10.  Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer.

Authors:  L F de Geus-Oei; H W M van Laarhoven; E P Visser; R Hermsen; B A van Hoorn; Y J L Kamm; P F M Krabbe; F H M Corstens; C J A Punt; W J G Oyen
Journal:  Ann Oncol       Date:  2007-10-24       Impact factor: 32.976

View more
  19 in total

1.  Prone position [18F]FDG PET/CT to reduce respiratory motion artefacts in the evaluation of lung nodules.

Authors:  Hyung Ju Lee; Hye Joo Son; Mijin Yun; Jung Won Moon; Yoo Na Kim; Ji Young Woo; Suk Hyun Lee
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

2.  Derivation of a respiration trigger signal in small animal list-mode PET based on respiration-induced variations of the ECG signal.

Authors:  Andrei Todica; Sebastian Lehner; Hao Wang; Mathias J Zacherl; Katharina Nekolla; Erik Mille; Guoming Xiong; Peter Bartenstein; Christian la Fougère; Marcus Hacker; Guido Böning
Journal:  J Nucl Cardiol       Date:  2015-06-12       Impact factor: 5.952

Review 3.  PET in the management of locally advanced and metastatic NSCLC.

Authors:  Willem Grootjans; Lioe-Fee de Geus-Oei; Esther G C Troost; Eric P Visser; Wim J G Oyen; Johan Bussink
Journal:  Nat Rev Clin Oncol       Date:  2015-04-28       Impact factor: 66.675

Review 4.  Respiratory-gated PET/CT for pulmonary lesion characterisation-promises and problems.

Authors:  Russell Frood; Garry McDermott; Andrew Scarsbrook
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

5.  Development of matrix metalloproteinase-targeted probes for lung inflammation detection with positron emission tomography.

Authors:  Naoya Kondo; Takashi Temma; Kazuki Aita; Saeka Shimochi; Kazuhiro Koshino; Michio Senda; Hidehiro Iida
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

Review 6.  Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET.

Authors:  Charlotte S van der Vos; Daniëlle Koopman; Sjoerd Rijnsdorp; Albert J Arends; Ronald Boellaard; Jorn A van Dalen; Mark Lubberink; Antoon T M Willemsen; Eric P Visser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-08       Impact factor: 9.236

7.  The Efficiency of Respiratory-gated 18F-FDG PET/CT in Lung Adenocarcinoma: Amplitude-gating Versus Phase-gating Methods.

Authors:  Yoshiyuki Kitamura; Shingo Baba; Takuro Isoda; Yasuhiro Maruoka; Satoshi Kawanami; Kazuhiko Himuro; Masayuki Sasaki; Hiroshi Honda
Journal:  Asia Ocean J Nucl Med Biol       Date:  2017

8.  Respiratory Gating and the Performance of PET/CT in Pulmonary Lesions.

Authors:  Cinzia Crivellaro; Luca Guerra
Journal:  Curr Radiopharm       Date:  2020

9.  Feasibility of Systematic Respiratory-Gated Acquisition in Unselected Patients Referred for 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.

Authors:  Philippe Robin; David Bourhis; Brieuc Bernard; Ronan Abgral; Solène Querellou; Alexandra Le Duc-Pennec; Pierre-Yves Le Roux; Pierre-Yves Salaün
Journal:  Front Med (Lausanne)       Date:  2018-02-19

10.  Evaluation of principal component analysis-based data-driven respiratory gating for positron emission tomography.

Authors:  Matthew D Walker; Kevin M Bradley; Daniel R McGowan
Journal:  Br J Radiol       Date:  2018-03-15       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.